CTIS2023-509178-44-00RecruitingPhase 1
Avian and seasonal influenza vaccine induced immune responses - Avian_inf_vacc_THL20
Finnish Institute For Health And Welfare0 sites300 target enrollmentStarted: December 21, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Enrollment
- 300
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 65+ (—)
- Sex
- All
Inclusion Criteria
- •Age 18 to 65 years, Belongs to the target group of the avian influenza vaccine, Is planning to receive at least one dose of the avian influenza vaccine, Is able to understand the given written and oral information, Has given written informed consent, Home address in Finland, Is able to give samples 3 weeks after each vaccine dose and preferably also participate in the follow-up at 6 and 12 months, Pregnant and lactating women can participate in the study
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Active, not recruiting
Phase 1
Effectiveness of infuenza vaccination in patients with breast cancer treatedwith trastuzumab postoperativelyEfficacy of vaccination against influenza in patients with breast cancertreated with Trastuzumab as adjuvant therapyEUCTR2015-003106-16-SEAntonis Valachis
Recruiting
Phase 4
Immune responses in health care personnel2024-515372-12-00Finnish Institute For Health And Welfare1,500
Terminated
Not Applicable
sing influenza vaccination to understand and improve immune responses to vaccination in patients with chronic obstructive pulmonary disease (COPD) and healthy older people.Chronic Obstructive Pulmonary DiseaseInfluenza viral diseaseRespiratory - Chronic obstructive pulmonary diseaseInfection - Other infectious diseasesACTRN12620000830998Princess Alexandra Hospital171
Completed
Not Applicable
Evaluation of immunogenicity of influenza vaccine in childreKCT0006127Korea University Ansan Hospital130
Completed
Not Applicable
Research on influenza vaccine immunogencity in infants.influenzaJPRN-C000000241The Research Foundation for Microbial Diseases of Osaka University200